SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased social activity and trading volume as investors discuss its technical strengths, including post-quantum security and real-world asset (RWA) potential. The community is actively debating the impact of recent leadership changes and the broader market's anticipation of upcoming regulatory clarity.

Maul Coin

Maul Coin is generating buzz as an early-stage community-driven project, with supporters actively rallying to increase its holder count and social media presence in hopes of driving a significant market cap expansion. The community is focused on organic growth and transparency, eagerly awaiting official charting status while coordinating promotional efforts across various platforms to maintain momentum.

GraniteShares ETF Trust - GraniteShares 2x Long COIN Daily ETF

GraniteShares 2x Long COIN Daily ETF

CONL is trending as the community closely monitors the upcoming Senate Banking Committee markup of the CLARITY Act, viewing potential regulatory progress as a major catalyst for Coinbase and the broader crypto sector. Investors are also actively debating its long-term viability, with many using the stock's recent volatility to accumulate positions in anticipation of a potential rebound linked to Coinbase's earnings and Bitcoin's price trajectory.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is trending as investors debate its long-term potential following a steep post-launch decline, with the community split between those accumulating at current price levels and others concerned about future token dilution. Supporters are actively discussing the project's high staking rewards and parallel processing technology as indicators of future value, while critics highlight low network activity and a challenging broader crypto market environment.

What is DigiByte? DigiByte is more than a faster digital currency. It is an innovative blockchain that can be used for digital assets, smart contracts, decentralized applications and secure authentication.   What makes DigiByte stronger than others? DigiByte is a rapidly growing open-source blockchain created in late 2013 and released in early 2014. After 6 years of forward thinking development, DigiByte has become one of the safest, fastest, longest and most decentralized UTXO blockchain in existence.   Truly Decentralized. DigiByte has never been funded through an ICO or significant amount of premined coins. There is no CEO or a company controlling the DigiByte blockchain. It is a volunteer based and global community driven project.   More secure. DigiByte uses 5 cryptographic algorithms and real time difficulty adjustment to prevent malicious mining centralization and hash power fluctuation. One of which is Odocrypt that changes itself every 10 days for ASIC resistance.   Much faster. DigiByte blocks occur every 15 seconds which is 40x faster than Bitcoin and 10x faster than Litecoin. Early SegWit implementation and blockchain rigidity enable up to 1066 on-chain transactions per second with negligible fees.   Forward thinking. Over the past 6 years, DigiByte has repeatedly set itself apart with multiple blockchain firsts, such asDigiShield guard, MultiAlgo mining, SegWit implementation, Odocrypt algorithm, Dandelion++ privacy protocol, DigiAssets and Digi-ID.       This is how the DigiByte blockchain works. The three layers are the most innovative parts of the DigiByte blockchain providing the network infrastructure, security and communications to function with cutting edge speed.    Applications / DigiAssets. The top layer is like an app store with clear real-world uses. All types of digital assets can be created with the DigiAssets protocol on top of the DigiByte blockchain. Decentralized applications (dApps) can be built on top of the DigiByte blockchain. Also smart contracts that leverage the rigidity and security of the DigiByte blockchain can be encoded easily.   Digital asset / Public ledger. The middle layer provides security and administration. A Digital Byte of data, a representation of larger data or a unit that holds value, and cannot be counterfeited, duplicated or hacked. An immutable public ledger where all transactions of DigiBytes are recorded. DigiByte uses five proof of work algorithms for security. New DigiBytes come from mining only.   Core protocol / Global network. The bottom layer provides communication and operating procedures. A very low-level way nodes on the DigiByte global network communicate. Thousands of people are running DigiByte software all across the planet. Any server, computer, tablet or mobile phone connected to the DigiByte network becomes a node that helps relay transactions.    Open source / Permissionless. Just like the DigiByte.io website, the DigiByte blockchain is completely open source and free to use released under the MIT license, which gives you the power to run and modify the software. Transparency allows for independent verification of binaries and their corresponding source code.        A digital currency you would absolutely love. DigiByte (DGB) is a highly scalable peer-to-peer digital currency that enables industry-leading transaction speeds with negligible fees. DigiByte is the best way for payments.   Easy to use. Getting started to use DigiByte is even easier than sending an SMS. You can send and receive DigiBytes using the devices you already know and love. All you need is installing a DigiByte supported wallet then click scan, scan the QR code and send DigiByte. As easy as 1..2..3.   Not an ICO. DigiByte has never been funded through an ICO or significant amount of premined coins (0% remaining). There is no CEO or a company controlling the DigiByte blockchain. The founder, developers and the community are unpaid volunteers that eliminate the bankrupt risk.   Much faster. DigiByte transactions are confirmed in approx. 15 seconds, which is 40 times faster than Bitcoin and 10 times faster than Litecoin. SegWit enables up to 1066 on-chain transactions per second and negligible fees make DigiByte the ideal currency for daily payments.    Always secure. DigiByte has been built on the uncrackable technology of the Bitcoin blockchain and implemented various advanced enhancements over it such as DigiShield guard, MultiAlgo mining and the Odocrypt algorithm. Also Dandelion++ privacy protocol helps keep you safe by hiding your IP and physical location. Learn more.   Mineable. DigiByte is a 100% Proof of Work (PoW) blockchain that can be mined with five algorithms called Sha256, Scrypt, Skein, Qubit and Odocrypt. MultiAlgo mining contributes to decentralization, security of the network and gives you the freedom to use different kind of hardware's such as an ASIC a FPGA or a GPU. Learn more.   Manageable units Compared to 21 million Bitcoin, 21 billion DigiByte (1000:1 ratio to BTC) have been designed to be ready for mass adoption. DigiByte block rewards reduces by 1% every month instead of halving every 4 years. All 21 billion DigiByte will be mined by the year 2035. After 2035 the miners will then rely on transaction fees alone. Learn more.     A simplified way to create digital assets. DigiAssets is a secure, scalable layer on top of the DigiByte blockchain that allows for the decentralized issuance of assets, tokens, smart contracts, digital identity and more.   Limitless possibilities. DigiAssets can be used to securely represent anything we find in the physical world. From tangible assets such as real estate or cars, through to scarce digital pieces of art. Signed documents such as deeds and medical bills can be protected.   Growing confidently. DigiAssets as an ecosystem and platform already has interested parties either planning on or currently building platforms in real estate, finance, remittance, identity, point of sale, racing, trade, healthcare, supply chain, government and more.   Solid technology. DigiAssets leverages unique aspects of a truly decentralized blockchain only found within a permissionless blockchain like DigiByte. This allows DigiAssets to be more secure, scalable and decentralized than any other platform in the market.      Authentication at its best. Digi-ID is a security protocol built on DigiByte blockchain technology that empowers users to effortlessly sign-in to websites, applications, and even into the internet of things.    Easy authentication. Digi-ID eliminates the username, password and 2fa requirements for authentication. Because Digi-ID uses public / private key cryptography, there are no passwords or usernames at risk. This method not only protects the consumer, it also protects the services that the consumer uses.    Flawless security. Digi-ID does not store any data about its users on the DigiByte blockchain. This further strengthens the security while also bolstering end-user’s confidence that their data is neither tracked nor at risk by others negligence. There is no external point of failure for an hacker to exploit your platform.   Simple and free. Digi-ID is completely free! There are no fees, subscription services, or maintenance costs. But the cost is its second best feature. Its primary feature is that, in accordance with DigiBytes security prioritization, Digi-ID is a more secure, yet simple method available to log in to websites, apps and more.     The most passionate community ever! Tens of thousands of volunteers from all over the world have contributed to DigiByte in countless ways for years to make it what it is today. It is a truly grassroots movement. We warmly welcome you to join us!   DigiByte Foundation. The DigiByte Foundation is a volunteer managed organization that operates in a non-profit way. They protect and promote the true principles of decentralization and empower DigiByte and its community to establish and maintain a sustainable decentralized world. Learn more.    DigiByte Awareness Team.  DGBAT is a community-driven outreach initiative. They are led by a team, whose members in turn manage teams across social media, outreach, education, writers and developers. They aim to promote the DigiByte blockchain through education, outreach and marketing campaigns. Learn more.    DigiByte Developers.  Everyone that is working on the DigiByte blockchain is an unpaid volunteer who devoted their time and skills to a project they believe in. Start contributing to the DGB development today or build your own app on top of the DigiByte blockchain. DigiByte Protocol on GitHub. DigiByte Core Development on GitHub.   The DigiByte Wiki. The DigiByte Wiki is an online encyclopedia built by the community, for the community. It contains useful and up to date data such as the DigiByte Ecosystem and how to guides. Anyone can positively contribute to the Wiki by creating a free user account and start adding or updating information on the DigiByte Wiki.    Meet the creator of DigiByte. Jared Tate is the founder and creator of the DigiByte blockchain. Jared dedicated full-time development towards DigiByte since October 2013. He has been invited by MIT, Harvard and the US Capitol to speak on blockchain tech. He is also the author of the book Blockchain 2035 The Digital DNA of Internet 3.0, which is the first book written by a blockchain founder.

DigiByte

DigiByte is attracting attention as the community anticipates the activation of Taproot, which promises to enhance network privacy and efficiency. Traders are actively discussing long-term accumulation strategies while debating the coin's potential as a scalable alternative to Bitcoin, despite recent periods of market volatility.

Bitcoin SV (BSV) emerged following a hard fork of the Bitcoin Cash (BCH) blockchain in 2018, which had in turn forked from the BTC blockchain a year earlier. The goal of Bitcoin SV is to fulfil the original vision of the Bitcoin protocol and design as described in Satoshi Nakamoto’s white paper, early Bitcoin client software and known Satoshi writings. BSV aims to offer scalability and stability in line with the original description of Bitcoin as a peer-to-peer electronic cash system, as well as deliver a distributed data network that can support enterprise-level advanced blockchain applications. To this end, it has removed artificial block size limits and re-enabled Script commands and other technical capabilities which had been historically disabled or restricted by the protocol developers of the BTC blockchain. This allows the network to process tens of thousands of transactions per second while maintaining extremely low transaction fees for micropayments, in addition to offering advanced capabilities such as tokens, smart contracts, computation and other data use cases. The BSV network is unique in its capacity for unbounded on-chain scaling while also being more aligned with the original design of Bitcoin than any other blockchain.

Bitcoin SV

Bitcoin SV is trending as the community closely monitors the outcome of the high-profile court battle involving Craig Wright, while simultaneously celebrating technical milestones like the Teranode testnet's ability to process over a million transactions per second. Investors are actively debating the token's long-term utility as the original Bitcoin protocol versus its significant regulatory hurdles and recent legal rulings, with many HODLers pointing to its scalability and low-cost microtransactions as catalysts for a potential rebound.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

The Zebec Network (ZBCN) community is actively debating the project's long-term utility versus its recent price performance, with many holders focusing on institutional partnerships and the potential for a breakout following the conclusion of token unlocks. While skeptics highlight the high circulating supply and recent downward trends, advocates remain bullish on the network's integration into payroll systems and anticipated announcements at industry events.

The ArcBlock project was created to create the first Blockchain ecosystem in the world. Develop and develop decentralized applications (DApp) according to objectives. ArcBlock, one of the ICO projects emerging in early 2018. Just launched on 3/1/2018, ArcBlock has quickly attracted the attention of technology as well as investors. ArcBlock brings great technological advancements that will open the third generation of blockchain applications.  Arcblock work by bridging the gap between different blockchains and their respective ecosystems has not been easy. There are some solutions which attempt to solve this problem, but it is evident there is plenty of room for competition in this regard. Building an open chain access layer capable of spanning multiple new and existing blockchains is a very interesting business model.  Building a new ecosystem meant to connect various chains will not be easy. As of right now, the team has completed its token sale, and the first public release candidate for the Open Chain Access Protocol will be released in Q3. Early 2019 will herald the introduction of more technical features and an Ethereum Blocklet prototype.

ArcBlock (ABT) is seeing heightened market activity and increased trading volume as community members speculate on potential AI integration and exchange listings, sparking both bullish price targets and skepticism regarding the project's utility. Conversations are dominated by long-term holders debating the legitimacy of recent partnership announcements and the token's ability to sustain upward momentum amid ongoing volatility.

EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is currently experiencing significant market attention, driven by institutional accumulation and investor anticipation regarding pivotal Phase 3 trial data for Duravyu. The community is actively debating the company's competitive positioning, specifically evaluating its Duravyu candidate against rival TKI treatments in the wet AMD and DME markets, while monitoring ongoing legal developments and management's strategic communication.

RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA.

RTX Corp

Raytheon Technologies Corporation

RTX is trending as investors weigh significant contract wins and defense production surges against broader market volatility linked to rising geopolitical tensions in the Middle East. The community is actively debating the stock's ability to maintain its upward momentum as defense names rotate in and out of favor amid reports of record spending budgets and potential margin pressure from production scaling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>ERNA-101 is designed to activate and regulate the immune system's response to recognize and attack cancer cells.</li><li>The new collaboration comes as the company looks forward to clinical trials for the cell therapy.&nbsp;</li><li>ERNA-101 has shown potential to reprogram immunologically "cold" tumors into "hot" ones, increasing immune cell infiltration and suppressing tumor growth in preclinical studies. &nbsp;</li></ul><blockquote>Shares of Ernexa Therapeutics (ERNA) traded 48% higher on Wednesday afternoon after Cellipont Bioservices announced that it has entered into a collaboration with the company.</blockquote>Cellipont is a cell therapy contract development and manufacturing organization. Its <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/cellipont-bioservices-and-ernexa-therapeutics-enter-cell-therapy-manufacturing-partnership-to-advance-erna-101-toward-clinical-trials-in-ovarian-cancer-302597673.html">partnership</a> with Ernexa will focus on activities to advance Ernexa’s lead cell therapy called ERNA-101 for the treatment of ovarian cancer into clinical manufacturing and trials.<blockquote>"Cellipont brings deep technical capabilities and a shared sense of urgency to help us translate the promise of ERNA-101 into a clinically viable therapy."&nbsp; -Sanjeev Luther, CEO, Ernexa Therapeutics.</blockquote><h2 class="st-heading-2">About The Cell Therapy</h2>ERNA-101 is designed to activate and regulate the immune system's response to recognize and attack cancer cells. According to Cellipont, it provides a scalable, off-the-shelf treatment, without needing patient-specific cell harvesting, provided it is an allogeneic iMSC therapy using stem cells from a healthy donor rather than the patient themselves.ERNA-101 has shown potential to reprogram immunologically "cold" tumors into "hot" ones, increasing immune cell infiltration and suppressing tumor growth in preclinical studies, the company said. The new collaboration comes as the company looks forward to clinical trials for the cell therapy.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/ERNA">ERNA stock</a> jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.A Stocktwits user expressed optimism for the stock hitting a new high.<stembedurl>https://stocktwits.com/Roza11/message/634186263</stembedurl>Another, however, sees upcoming dilution.<stembedurl>https://stocktwits.com/Tradebub/message/634144629</stembedurl>ERNA stock is down by 58% this year and by 89% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/bridgebio-shares-second-postive-late-stage-study-results-in-a-week-calcium-disorder-drug-trial-yields-positive-results/cLGZvEeR3DT">BridgeBio Shares Second Positive Late-Stage Study Result In A Week – Calcium Disorder Drug Trial Yields Positive Results</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

ERNA Stock Rallies On Collaboration With Contract Manufacturer To Advance Lead Cell Therapy Into Clinical Trials 

The partnership will focus on activities to advance Ernexa’s lead cell therapy called ERNA-101 for the treatment of ovarian cancer into clinical manufacturing and trials. 

Equity

Cellipont Bioservices and Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership to Advance ERNA-101 Toward Clinical Trials in Ovarian Cancer

Cellipont Bioservices and Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership to Advance ERNA-101 Toward Clinical Trials in Ovarian Cancer Cellipont Bioservices and Ernexa Therapeutics...

Shares of Ernexa Therapeutics (ERNA) fell 13% on Tuesday morning after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/06/10/3096816/0/en/Ernexa-Therapeutics-Announces-1-for-15-Reverse-Stock-Split.html">announced</a> a reverse stock split to regain compliance with the $1 minimum bid price required for continued listing on Nasdaq.The reverse stock split will be at a ratio of 1-for-15, effective June 12, 2025, at 12:01 a.m. Eastern Time. The company’s common stock is expected to begin trading on a split-adjusted basis when the market opens on June 12.As a result of the reverse stock split, every 15 shares of the company’s common stock issued and outstanding will be automatically reclassified into one new share of common stock.No fractional shares will be issued in connection with the reverse stock split, and no cash or other consideration will be paid in connection with any fractional shares.As of Tuesday, the company had 110.4 million shares of common stock issued and outstanding, which it anticipates will result in approximately 7.4 million shares of common stock issued and outstanding on a split-adjusted basis.Ernexa also stated that it believes the reverse stock split is a key step in strengthening its financial foundation and maintaining access to the capital markets needed to advance its clinical programs.Ernexa is developing innovative stem cell therapies for the treatment of advanced cancer and autoimmune disease.On Stocktwits, retail sentiment around Ernexa improved from ‘extremely bearish’ to ‘bearish’ territory over the past 24 hours while message volume remained at ‘high’ levels.<figure class="image"><img style="aspect-ratio:629/57;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_10_at_10_35_28_AM_png_969f4ebcc6.webp" alt="ERNA's Sentiment Meter and Message Volume as of 10:30 a.m. ET on June 10, 2025 | Source: Stocktwits" width="629" height="57"><figcaption>ERNA's Sentiment Meter and Message Volume as of 10:30 a.m. ET on June 10, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/ERNA">ERNA stock</a> is down by about 56% this year and by about 91% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/tencent-music-expands-audio-empire-with-over-2-billion-ximalaya-merger/chl7VcFRbzk">Tencent Expands Audio Empire With $2.4B Ximalaya Merger: Retail Turns Optimistic</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Ernexa Stock Drops On 1-For-15 Reverse Stock Split To Regain Nasdaq Compliance: Retail Sentiment Improves But Stays Bearish

As of Tuesday, the company had 110.4 million shares of common stock issued and outstanding, which it anticipates will result in approximately 7.4 million shares on a split-adjusted basis.

This account has been verified as an official ERNA representative.

Verified Account

Ernexa Therapeutics

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

ERNA
Ernexa Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest ERNA News

ERNAErnexa Therapeutics Inc